Literature DB >> 17880918

Overexpression of Mitofusin 2 inhibited oxidized low-density lipoprotein induced vascular smooth muscle cell proliferation and reduced atherosclerotic lesion formation in rabbit.

Yan-Hong Guo1, Kuanghueih Chen, Wei Gao, Qian Li, Li Chen, Gui-Song Wang, Jian Tang.   

Abstract

Our previous studies have implies that Mitofusin 2 (Mfn2), which was progressively reduced in arteries from ApoE(-/-) mice during the development of atherosclerosis, may take part in pathogenesis of atherosclerosis. In this study, we found that overexpression of Mfn2 inhibited oxidized low-density lipoprotein or serum induced vascular smooth muscle cell proliferation by down-regulation of Akt and ERK phosphorylation. Then we investigated the in vivo role of Mfn2 on the development of atherosclerosis in rabbits using adenovirus expressing Mitofusin 2 gene (AdMfn2). By morphometric analysis we found overexpression of Mfn2 inhibited atherosclerotic lesion formation and intima/media ratio by 66.7% and 74.6%, respectively, compared with control group. These results suggest that local Mfn2 treatment suppresses the development of atherosclerosis in vivo in part by attenuating the smooth muscle cell proliferation induced by lipid deposition and vascular injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880918     DOI: 10.1016/j.bbrc.2007.08.191

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Regulating a uniter: control of mitofusin 2 expression.

Authors:  Anne A Knowlton; Le Chen
Journal:  Cardiovasc Res       Date:  2012-02-23       Impact factor: 10.787

Review 2.  Mitochondrial morphology and cardiovascular disease.

Authors:  Sang-Bing Ong; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2010-07-14       Impact factor: 10.787

Review 3.  Mitochondrial Dynamics and Heart Failure.

Authors:  A A Knowlton; T T Liu
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

Review 4.  Sarcoplasmic reticulum-mitochondria communication in cardiovascular pathophysiology.

Authors:  Camila Lopez-Crisosto; Christian Pennanen; Cesar Vasquez-Trincado; Pablo E Morales; Roberto Bravo-Sagua; Andrew F G Quest; Mario Chiong; Sergio Lavandero
Journal:  Nat Rev Cardiol       Date:  2017-03-09       Impact factor: 32.419

Review 5.  Mitochondrial dynamics in cardiovascular health and disease.

Authors:  Sang-Bing Ong; Andrew R Hall; Derek J Hausenloy
Journal:  Antioxid Redox Signal       Date:  2012-09-10       Impact factor: 8.401

Review 6.  Redox control of vascular smooth muscle cell function and plasticity.

Authors:  Brittany G Durgin; Adam C Straub
Journal:  Lab Invest       Date:  2018-02-20       Impact factor: 5.662

Review 7.  Emerging roles of mitochondria ROS in atherosclerotic lesions: causation or association?

Authors:  Ying Wang; Ira Tabas
Journal:  J Atheroscler Thromb       Date:  2014-04-08       Impact factor: 4.928

Review 8.  Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics.

Authors:  Emanuele Marzetti; Anna Csiszar; Debapriya Dutta; Gauthami Balagopal; Riccardo Calvani; Christiaan Leeuwenburgh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-07       Impact factor: 4.733

9.  Mitofusin2 decreases intracellular cholesterol of oxidized LDL-induced foam cells from rat vascular smooth muscle cells.

Authors:  Chao He; Ying Chen; Chun Liu; Ming Cao; Yu-Jin Fan; Xiao-Mei Guo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-04-17

10.  Glucagon-like peptide-1 inhibits vascular smooth muscle cell dedifferentiation through mitochondrial dynamics regulation.

Authors:  Gloria Torres; Pablo E Morales; Marina García-Miguel; Ignacio Norambuena-Soto; Benjamín Cartes-Saavedra; Gonzalo Vidal-Peña; David Moncada-Ruff; Fernanda Sanhueza-Olivares; Alejandra San Martín; Mario Chiong
Journal:  Biochem Pharmacol       Date:  2016-01-22       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.